Hypogonadism in men is commonly treated with testosterone replacement therapy. Kyzatrex (Marius Pharmaceuticals), a novel oral testosterone undecanoate (TU) formulation, is conventionally initiated at a dose of 200 mg BID. However, many patients attain greater symptomatic benefit at higher doses. In ...
Durability of the Effects of Testosterone and Growth Hormone Supplementation in Older Community Dwelling Men: The HORMA Trial SummaryObjectives To determine the durability of anabolic effects and adverse events (AEs) after stopping testosterone and growth hormone supplementation i... FR Sattler,S Bhasin...